Summary
- Current Price
- As of today, ARCT price is $6.08, down -2.88% on
- Current Price All-Time High
- ARCT price is currently -96.78% below its historical high of $188.72 set on
- Market Cap
- ARCT current market cap is $173M, down -46.87% year-over-year
- Revenue
- ARCT current annual revenue is $67.22M, down -51.43% year-over-year
- Next Earnings
- As of today, the next earnings release for ARCT has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Arcturus Therapeutics Holdings Inc. |
| Ticker | NASDAQ: ARCT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arcturusrx.com |
| Employees | 174 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $6.08 | ||
| Price, 1D Change | -2.88% | |
| $173M | ||
| - | ||
| - | ||
| 2.18 | ||
| $67.22M | ||
| Revenue, 1Y Change | -51.43% | |
| -$2.40 | ||
| EPS, 1Y Change | +19.87% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:7 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ADHD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.40 | ||
| EPS Estimate | -$3.86 | N/A |
| EPS Est. Change | -60.59% | N/A |
| $67.22M | ||
| Revenue Estimate | $22.00M | N/A |
| Revenue Est. Change | -67.27% | N/A |
| $6.08 | ||
| Price Target | $20.50 | - |
| Price Tgt. Change | +237.17% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.38 | -$3.00 | -25.95% | |
| -$2.12 | -$2.40 | -13.44% | |
| -$3.86 | N/A | -60.59% | |
| -$4.02 | N/A | -67.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $174.23M | $138.39M | -20.57% | |
| $90.47M | $67.22M | -25.69% | |
| $22.00M | N/A | -67.27% | |
| $33.04M | N/A | -50.86% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -49.25% | ||
| -80.91% | ||
| -46.87% | ||
| -79.58% | ||
| -51.43% | ||
| -67.37% | ||
| +19.87% | ||
| -796.06% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $6.08 | ||
| $7.60 | ||
| $6.80 | ||
| $8.58 | ||
| $6.66 | ||
| -$0.23 | ||
| 2.18 | ||
| $0.34 | ||
| 44.53 | ||
| 49.37% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $67.22M | ||
| -$2.40 | ||
| $64.20M | ||
| 95.50% | ||
| -$74.96M | ||
| -111.51% | ||
| -$65.78M | ||
| -97.86% | ||
| -$71.93M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.12 | ||
| 6.64 | ||
| 6.64 | ||
| - | ||
| 3 | ||
| -0.60 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 4.08 | ||
| 0.90 | ||
| 0.17 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $213.99M | ||
| $230.91M | ||
| $271.15M | ||
| $241.45M | ||
| $57.16M | ||
| $36.38M | ||
| $25.00M | ||
| $4.21M | ||
| $4.24M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $133.00M | ||
| $139.15M | ||
| $3.03M | ||
| $0.00 | ||
| $3.03M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$74.27M | ||
| -$230.00K | ||
| $13.38M | ||
| $230.00K | ||
| -$74.50M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Freedom Broker | ||
| B. Riley Securities | → | |
| Citigroup | → | |
| Piper Sandler | → | |
| Citigroup | → | |
| Citigroup | → | |
| Citigroup | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ARCT
FAQ
- What is the ticker symbol for Arcturus Therapeutics Holdings Inc.?
- The ticker symbol for Arcturus Therapeutics Holdings Inc. is NASDAQ:ARCT
- Does Arcturus Therapeutics Holdings Inc. pay dividends?
- No, Arcturus Therapeutics Holdings Inc. does not pay dividends
- What sector is Arcturus Therapeutics Holdings Inc. in?
- Arcturus Therapeutics Holdings Inc. is in the Healthcare sector
- What industry is Arcturus Therapeutics Holdings Inc. in?
- Arcturus Therapeutics Holdings Inc. is in the Biotechnology industry
- What country is Arcturus Therapeutics Holdings Inc. based in?
- Arcturus Therapeutics Holdings Inc. is headquartered in United States
- When did Arcturus Therapeutics Holdings Inc. go public?
- Arcturus Therapeutics Holdings Inc. initial public offering (IPO) was on May 22, 2013
- Is Arcturus Therapeutics Holdings Inc. in the S&P 500?
- No, Arcturus Therapeutics Holdings Inc. is not included in the S&P 500 index
- Is Arcturus Therapeutics Holdings Inc. in the NASDAQ 100?
- No, Arcturus Therapeutics Holdings Inc. is not included in the NASDAQ 100 index
- Is Arcturus Therapeutics Holdings Inc. in the Dow Jones?
- No, Arcturus Therapeutics Holdings Inc. is not included in the Dow Jones index
- When was Arcturus Therapeutics Holdings Inc. last earnings report?
- Arcturus Therapeutics Holdings Inc.'s most recent earnings report was on August 6, 2026
- When does Arcturus Therapeutics Holdings Inc. report earnings?
- The date for Arcturus Therapeutics Holdings Inc.'s next earnings report has not been announced yet
Data Sources & References
- ARCT Official Website arcturusrx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1768224/000119312526088391/0001193125-26-088391-index.htm
- ARCT Profile on Yahoo Finance finance.yahoo.com/quote/ARCT
- ARCT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arct